Editorial Board

Dr. Teruhiko Shimokawa, Ph.D., R.Ph.

Dr. Teruhiko Shimokawa, Ph.D., R.Ph.
Team-Innovation Lead
Science Evaluation and Intelligence, Research Portfolio Planning, Drug Discovery Research,
Astellas Pharma Inc., Tsukuba,

Biography :

Professional experiences: Science Evaluation for a drug discovery research in the field of ear disease (2015) and kidney/urological diseases (2014); Global Project Management Lead in the development (2012); Director, National project management at Biotechnology and Medical Technology Department, New Energy and Industrial Technology Development Organization, Japan (2011); A drug discovery research management for metabolic disease programs (1997)

Research Interest :

A novel gene and cell therapy for intractable inner ear disease, Molecular biology of hearing loss, A new treatment of genetic disease in the field of molecular otolaryngology, Regeneration of hair cells/auditory neurons